Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Ocoxin × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3 Gynecologic 2 Sarcoma 1 Lymphoid 1 Head & Neck 1 CNS 1 Breast 1

Conditions

Breast Neoplasms 1

Interventions

Trastuzumab 636 Paclitaxel 605 Cyclophosphamide 567 Docetaxel 498 Capecitabine 443 Letrozole 382 Fulvestrant 347 Carboplatin 344 Doxorubicin 303 Tamoxifen 276 Anastrozole 238 pembrolizumab 237 exemestane 222 Radiotherapy 221 Epirubicin 213 Bevacizumab 199 pertuzumab 197 palbociclib 189 Gemcitabine 189 Vinorelbine 180 Lapatinib 166 130-nm albumin-bound paclitaxel 150 Magnetic Resonance Spectroscopy 149 Albumin-Bound Paclitaxel 138 eribulin 137 Surveys and Questionnaires 135 Exercise 131 Drug Therapy 119 Fluorouracil 116 Taxes 113

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03576521 2018-07-03

Evaluation of Ocoxin®-Viusid® in Breast Cancer

Catalysis SL

Phase 2 Completed

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡